Warning: Undefined array key "post_type" in /home/oncologycongress/public_html/wp-content/plugins/brave-popup-builder/lib/render.php on line 330

Warning: Undefined array key "post_type" in /home/oncologycongress/public_html/wp-content/plugins/brave-popup-builder/lib/render.php on line 330

Posts in 21 March 2022

Extended-Duration Prophylaxis With Letermovir May Reduce CMV Reactivation in HSCT

BOSTON—Extended-duration prophylactic therapy with letermovir (Prevymis, Merck) may reduce cytomegalovirus (CMV) reactivation in allogeneic hematopoietic stem cell […]
by mhAdmin
read more...